Spyre Therapeutics: Funding, Investors & Team (Oct 2026)
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies with the potential to revolutionize the treatment of inflammatory bowel disease (IBD).
Spyre Therapeutics has raised $403M across 1 funding round on record, the most recent an undisclosed round of $403M announced in Apr 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Spyre Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Spyre Therapeutics Funding Rounds
Spyre Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Spyre Therapeutics Funding Compared to Other Biotechnology Startups
Spyre Therapeutics' latest round of $403M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Spyre Therapeutics in Biotechnology and Sunrise
Companies Similar to Spyre Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Spyre Therapeutics Funding FAQs
What does Spyre Therapeutics do?
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies with the potential to revolutionize the treatment of inflammatory bowel disease (IBD).
How much funding has Spyre Therapeutics raised?
Spyre Therapeutics has raised $403M across 1 round on record. The most recent is an undisclosed round of $403M announced in Apr 2026.
When did Spyre Therapeutics last raise funding?
Spyre Therapeutics' most recent funding round on record is an undisclosed round of $403M, announced in Apr 2026.
Who founded Spyre Therapeutics?
FundedIQ lists Cameron Turtle (Founder) at Spyre Therapeutics.
Where is Spyre Therapeutics headquartered?
Spyre Therapeutics is based in Sunrise, Florida, United States.
How many employees does Spyre Therapeutics have?
Spyre Therapeutics is in the 101-250 employee band.
How does Spyre Therapeutics' funding compare to other Biotechnology startups?
Spyre Therapeutics' latest round of $403M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Spyre Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Spyre Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.